KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) EBITDA (2016 - 2026)

Historic EBITDA for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to $235.2 million.

  • Exelixis' EBITDA rose 4412.22% to $235.2 million in Q1 2026 from the same period last year, while for Jan 2026 it was $872.2 million, marking a year-over-year increase of 4425.51%. This contributed to the annual value of $872.2 million for FY2026, which is 4425.51% up from last year.
  • Exelixis' EBITDA amounted to $235.2 million in Q1 2026, which was up 4412.22% from $236.5 million recorded in Q4 2025.
  • Exelixis' EBITDA's 5-year high stood at $275.9 million during Q2 2024, with a 5-year trough of -$48.1 million in Q4 2022.
  • In the last 5 years, Exelixis' EBITDA had a median value of $83.5 million in 2022 and averaged $115.6 million.
  • Over the last 5 years, Exelixis' EBITDA had its largest YoY gain of 190688.08% in 2022, and its largest YoY loss of 14073.68% in 2022.
  • Over the past 5 years, Exelixis' EBITDA (Quarter) stood at -$48.1 million in 2022, then soared by 270.12% to $81.8 million in 2023, then skyrocketed by 66.38% to $136.1 million in 2024, then skyrocketed by 73.83% to $236.5 million in 2025, then dropped by 0.56% to $235.2 million in 2026.
  • Its last three reported values are $235.2 million in Q1 2026, $236.5 million for Q4 2025, and $213.6 million during Q3 2025.